Validation of a fluorescent imaging plate reader membrane potential assay for high-throughput screening of glycine transporter modulators.

A fluorescent imaging plate reader (FLIPR) membrane potential (Vm) assay was evaluated for pharmacological characterization and high-throughput screening (HTS) of rat glycine transporter type 2 (rGlyT2) in a stable rGlyT2-HEK cell line. Data show that glycine activation of rGlyT2 consistently results in a concentration-dependent Vm response on the FLIPR that is blocked by the potent and selective GlyT2 antagonist 4-benzyloxy-3,5-dimethoxy-N-[1-dimethylamino-cyclopentyl)methyl]-benz-amide (Org-25543). Agonist and antagonist pharmacologies match those reported using conventional [3H]glycine uptake assays and electrophysiology. The glycine response is dependent on buffer ionic composition consistent with GlyT2 physiology. Assay signal-to-background and coefficient of variation meets sufficient statistical criteria to conduct HTS. The results of a screen of the chemical inventory demonstrate that the assay is able to successfully identify and confirm GlyT2 inhibitors. The advantages of this assay are its homo...